Cascador Health acquires Galenus Health to jointly harness real-world data, bolster insights, and accelerate the adoption of novel therapies

Temse, 30th May 2024

Today, Cascador Health announced that it has successfully completed the acquisition and integration of Galenus Health. The acquisition of Galenus Health strengthens Cascador’s ecosystem and market position as a solutions provider that addresses the real-world data, evidence, and insights needs of life sciences, and drives additional value for Cascador, its clients, partners, investors and, above all, patients.

By joining forces, Cascador gains accelerated access to pharma sponsors and expands its European hospital network, whilst Galenus Health gets faster compliant access to crucial hospital data from health records through the Cascador RWD Access Platform. By integrating the ePROMS and Analytics solution of Galenus into the Cascador RWD Access Platform, Cascador becomes a one-stop shop for 360° real-world data.

The Cascador Health solutions portfolio now covers a comprehensive range of Market Access, Clinical Evidence, and Therapy Adoptions Solutions, for Pharma and MedTech across Europe, enabling the industry to harness real-world data for better patient outcomes.

Following the acquisition, Gert Marien, Managing Partner, cofounder and CEO of Galenus Health, assumes the role of Head of Sales, whilst Joost de Kinderen, Managing Partner and COO of Galenus Health, assumes the role of Head of Product & Insights Lab for Cascador Health.

About Cascador Health

Founded in 2021 by experienced entrepreneurs and digital specialists and backed by VCs, Cascador Health is a Belgian scale-up with a strong focus on unlocking real-world data for better health. Its proprietary approach with a Trusted Third Party and own data platform positions Cascador as a unique player to collect and harness data for secondary use in the most trusted, compliant and cost-efficient manner.

About Galenus

Founded in 2018, Galenus Health is a Belgian research and consultancy boutique in the Respiratory space. Its CHRINOSOR program encompasses the European Outcome Registry for Chronic Rhinosinusitis based on both patient-reported and physician-reported data, and brings together a network of big pharma sponsors and physicians from top European clinical centres. Galenus Health delivers real-world evidence and insights related to mainly biologics therapies through a series of multi-year multi-endpoint studies and scientific publications.